US Broker Ratings

AtriCure, Inc. (ATRC) Stock Analysis: A Strong Buy Consensus Despite High Valuation Metrics

AtriCure, Inc. (NASDAQ: ATRC) is making waves in the healthcare sector, presenting a compelling case for investors with its innovative medical instruments and an impressive market..

LeMaitre Vascular (LMAT) Stock Analysis: Healthcare Innovator with 26.91% Potential Upside

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands out in the medical instruments and supplies industry with its innovative solutions in vascular surgery. This Burlington, Massachusetts-based company, boasting..

NovoCure Limited (NVCR) Stock Analysis: Exploring an 86% Upside Potential in the Medical Device Sector

NovoCure Limited (NASDAQ: NVCR), a pioneering company in the healthcare sector, is capturing the attention of investors with its innovative approach to treating solid tumor cancers...

Recursion Pharmaceuticals (RXRX): Investor Outlook with 92.54% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a dynamic player in the biotechnology sector, continues to garner attention from investors due to its innovative approach to drug discovery..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring the 4% Potential Upside Amid Healthcare Sector Dynamics

Ardent Health, Inc. (NASDAQ: ARDT), a prominent player in the healthcare sector, has captured investor attention with its robust portfolio of medical care facilities across the..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a Promising 10.26% Potential Upside

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the healthcare sector, is gaining attention among investors for its robust performance and promising outlook. Specializing..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Navigating a 31% Upside Potential in the Biotech Sector

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a key player in the biotechnology sector, is capturing investor attention with its promising pipeline of therapies for rare neurological..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a 73.5% Upside Potential Amidst Biotech Volatility

Immunovant, Inc. (NASDAQ: IMVT), a burgeoning name in the biotechnology sector, is capturing investor attention with a compelling 73.5% potential upside, as gleaned from current analyst..

Progyny, Inc. (PGNY) Stock Analysis: Healthcare Innovator Poised for 22% Upside

Progyny, Inc. (NASDAQ: PGNY) is capturing the attention of investors with its innovative approach to healthcare benefits management, specifically in the fertility and family building sector...

Certara, Inc. (CERT) Stock Analysis: Navigating a Healthcare Investment with a 13.59% Downside Risk

Certara, Inc. (CERT), a key player in the healthcare sector, stands as a significant entity within the health information services industry. Headquartered in Radnor, Pennsylvania, this..

GeneDx Holdings Corp. (WGS): Investor Outlook Reveals 52.63% Potential Upside

GeneDx Holdings Corp. (NASDAQ: WGS), a pivotal player in the healthcare sector, is drawing significant attention from investors due to its promising potential for growth. Specializing..

Organon & Co. (OGN) Stock Analysis: Is Its Forward P/E of 3.82 a Hidden Gem for Investors?

Organon & Co. (NYSE: OGN), a notable player in the Healthcare sector, operates within the Drug Manufacturers – General industry. Despite its relatively modest market cap..

Viking Therapeutics (VKTX) Stock Analysis: Exploring a 292% Potential Upside in the Biotech Sector

Viking Therapeutics, Inc. (NASDAQ: VKTX) has recently captured the attention of investors with its promising potential upside of 292.62%, as indicated by current analyst ratings. Operating..

Denali Therapeutics Inc. (DNLI) Investor Outlook: 90% Potential Upside Amid Strong Buy Ratings

Denali Therapeutics Inc. (NASDAQ: DNLI) is capturing investor attention with a compelling potential upside of 90.25%, as revealed by the latest analyst ratings. This biopharmaceutical company,..

Protagonist Therapeutics (PTGX) Stock Analysis: Biotechnology Innovator with a 27% Upside Potential

Protagonist Therapeutics, Inc. (PTGX) is making waves in the biotechnology sector with a robust pipeline of innovative treatments targeting significant unmet medical needs. Headquartered in Newark,..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a Potential 54.64% Upside in the Biotech Sector

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, has piqued the interest of investors with its promising drug pipeline and potential for..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 38.74% Upside Potential in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a prominent player in the biotechnology industry, is capturing investor attention with its unique position in the healthcare sector. With a market..

CG Oncology, Inc. (CGON) Investor Outlook: Analyzing a Near 48% Upside Potential in Biotech

CG Oncology, Inc. (NASDAQ: CGON) is capturing the attention of investors with its promising potential in the biotechnology sector. Specializing in the development of innovative cancer..

Haemonetics Corporation (HAE): Exploring a 4.46% Potential Upside in the Medical Device Sector

Investors with an eye on the healthcare sector should take a closer look at Haemonetics Corporation (NYSE: HAE), a significant player in the medical devices industry...

Perrigo Company plc (PRGO) Stock Analysis: Is This 7.33% Dividend Yield Too Good to Ignore?

Perrigo Company plc (PRGO), headquartered in Dublin, Ireland, stands as a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds